Orviva

Learn · Variants · SLC2A2

rs8192675 SLC2A2

Enhanced metformin response. SLC2A2 variant associated with greater HbA1c reduction.

Curated · human-reviewed Drug response · Risk / effect allele: T · dbSNP

What is rs8192675?

rs8192675 is a single-nucleotide polymorphism (SNP) in the SLC2A2 gene (Solute carrier family 2 member 2 (GLUT2)). Each person carries two copies, one from each parent, so a result is reported as a pair of letters such as TT. The table below describes what studies associate with each genotype; the association is statistical, across populations, and is not a diagnosis.

What does each rs8192675 genotype mean?

GenotypeAssociationWhat the evidence saysConfidence
TTincreasedEnhanced metformin response. SLC2A2 variant associated with greater HbA1c reduction.75%
CT / TCtypicalSlightly enhanced metformin response.72%
CCtypicalStandard metformin response.75%

How common is the T allele of rs8192675?

Minor-allele frequency by population (gnomAD / 1000 Genomes):

European22.0%
East Asian10.0%
African18.0%
South Asian15.0%
Admixed American18.0%
Global17.0%

Which drugs have annotations for rs8192675?

PharmGKB clinical annotations (level 1A is the strongest evidence, 4 the weakest):

DrugAnnotation typeEvidence level
metforminEfficacy3

Is rs8192675 on 23andMe and AncestryDNA chips?

Yes — it is genotyped directly on 23andMe V3, 23andMe V4, 23andMe V5, AncestryDNA V1, AncestryDNA V2. Orviva reads it from a raw-data export without imputation.

Sources

Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.